Collectively, our results indicate that M2‐TAM infiltration and upregulated STAT3/NF‐κB pathways drive tumor proliferation, angiogenesis, EMT, and immunosuppression, leading to poor clinical outcomes. The gene discussed is STAT3; the disease is neoplasm.